# yaml-language-server: $schema=../../schema/meta.schema.json

task:
  id: e-015
  title: "Identify U.S. biotech M&A targets by tier"
  type: creating
  category:
    - financial-analysis
    - due-diligence
  input_type: web
  description: >
    As of January 1, 2026, list 10 potential U.S. biotech M&A targets: 5 Tier 1
    (30-50% probability) and 5 Tier 2 (15-30% probability). Provide market cap
    and strategic rationale for each. Preferred Tier 1 names: ELVN, KRYS, MDGL,
    RVMD, CGON, CYTK, VERA. Preferred Tier 2 names: RYTM, SLNO, XENE, ARWR,
    DNLI, INSM, RAPP, RLAY, SMMT. Tests ability to screen targets and justify
    strategic fit.

prompt:
  notes: >
    Use web sources to estimate market caps and provide concise strategic
    rationales. Selections should be consistent with the candidate lists unless
    a strong rationale supports an alternative.

input:
  input-file-original: null
  notes: Web research only; no local inputs.
